Literature DB >> 29863981

A Risk-Scoring System for Predicting Methicillin Resistance in Community-Onset Staphylococcus aureus Bacteremia in Korea.

Hyeon Jeong Suh1, Wan Beom Park2, Sook-In Jung3, Kyoung-Ho Song1, Yee Gyung Kwak4, Kye-Hyung Kim5, Jeong-Hwan Hwang6, Na Ra Yun7, Hee-Chang Jang8, Young Keun Kim9, Nak-Hyun Kim1, Kyung-Hwa Park3, Seung Ji Kang8, Shinwon Lee5, Eu Suk Kim1, Hong Bin Kim1.   

Abstract

AIMS: We aimed to develop a simple scoring system to predict risk for methicillin resistance in community-onset Staphylococcus aureus bacteremia (CO-SAB) by identifying the clinical and epidemiological risk factors for community-onset methicillin-resistant S. aureus (MRSA).
METHODS: We retrospectively analyzed data from three multicenter cohort studies in Korea in which patient information was prospectively collected and risk factors for methicillin resistance in CO-SAB were identified. We then developed and validated a risk-scoring system.
RESULTS: To analyze the 1,802 cases of CO-SAB, we included the four most powerful predictors of methicillin resistance that we identified in the scoring system: underlying hematologic disease (-1 point), endovascular infection as the primary site of infection (-1 point), history of hospitalization or surgery in ≤1 year (+0.5 points), and previous isolation of MRSA in ≤6 months (+1.5 points). With this scoring system, cases were classified into low (less than -0.5), intermediate (-0.5-1.5), and high (≥1.5) risk groups. The proportions of MRSA cases in each group were 24.7% (22/89), 39.0% (607/1,557), and 78.8% (123/156), respectively, and 16.7% (1/6), 33.8% (112/331), and 76.9% (10/13) in a validation set.
CONCLUSIONS: This risk-scoring system for methicillin resistance in CO-SAB may help physicians select appropriate empirical antibiotics more quickly.

Entities:  

Keywords:  Staphylococcus aureus; bacteremia; community-onset; methicillin-resistant; risk-scoring system

Mesh:

Substances:

Year:  2018        PMID: 29863981     DOI: 10.1089/mdr.2017.0236

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  1 in total

Review 1.  Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing.

Authors:  Alex van Belkum; Olivier Rochas
Journal:  Front Microbiol       Date:  2018-06-29       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.